RITTER PHARMACEUTICALS INC·4

Mar 13, 6:26 PM ET

Ritter Ira E. 4

4 · RITTER PHARMACEUTICALS INC · Filed Mar 13, 2020

Insider Transaction Report

Form 4
Period: 2020-03-04
Ritter Ira E.
DirectorExec. Chairman, CSO
Transactions
  • Sale

    Common Stock

    2020-03-04$0.38/sh18,750$7,04381,727 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By Trust)
    625
Footnotes (2)
  • [F1]As a managing partner of Stonehenge Partners LLC, the Reporting Person may be deemed the beneficial owner of these shares. The Reporting Person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
  • [F2]These shares are held in a retirement plan trust of which the Reporting Person and his spouse are trustees. The Reporting Person's spouse and the revocable trust of the Reporting Person and his spouse are beneficiaries of the retirement plan trust. The Reporting Person expressly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT